QSAM Biosciences Receives Clearance from FDA to Expand Enrollment Criteria in its Phase 1 Study of…
QSAM Biosciences, a company developing next generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam), for the treatment…